rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Granules India Ltd.

532482 GRANULES Group (A)

22 Jul,15:29
517.15
14.15 (2.81%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Granules India Ltd.

BUYSELL

47,904 503.00 520.00 - 494.60 530.40 - 287.55 12,535.72
NSE | BSE

Granules India Ltd.

GRANULES

22 Jul,15:58
517.80
14.80 (2.94%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Granules India Ltd.

BUYSELL

913,912 503.00 520.15 - 495.00 530.65 - 287.70 470,098,054.56

News for Granules India Ltd.

India-UAE Trade...
India-UAE Trade Pact: GTRI Raises Concerns Over Precious Metal Imports
GTRI expresses concerns about increased precious metal imports from UAE under the India-UAE CEPA, highlighting potential revenue loss and impact on domestic jewellery industry.
Jul 16, 2024 14:58
Lupin Sells...
Lupin Sells Women's Health Business to Evofem for $84 Million
Lupin has divested its US-based women's health speciality business to Evofem Biosciences for up to $84 million. The deal includes the commercialization of Solosec, an FDA-approved treatment for...
Jul 15, 2024 19:54
Granules India Promoter Sells 3.09% Stake for Rs 304 Crore
Krishna Prasad Chigurupati, promoter of Granules India, sold 3.09% stake for Rs 304 crore via open market transaction, reducing his holding to 31.69%.
May 22, 2024 19:13
Granules India Q4 Profit Up 8% to Rs 130 Cr
Granules India's Q4 profit rose 8% to Rs 130 crore, while revenue declined. The company's full-year profit was down 22%. Read more about the financial results and future outlook.
May 15, 2024 17:00
Granules India Gets USFDA Approval for Generic Gout Medication
Granules India receives USFDA approval to market Colchicine Capsules (0.6 mg) for gout prevention and treatment. The generic medication is therapeutically equivalent to Hikma International...
Apr 30, 2024 11:31

More News for Granules India Ltd. »

(Rs. Crore)

Financial Results of Granules India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,755.093,931.203,238.443,134.982,309.93
Operating profit801.36838.24644.65861.37494.14
Interest72.0038.6716.3523.7726.86
Gross profit735.14809.50645.81851.32493.73
EPS (Rs)17.9920.6115.5822.3217.47

See more in Research Center »

About Granules India Ltd.

Granules India Limited is an Indian multinational pharmaceutical manufacturing company based in Hyderabad. Granules manufactures several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Granules India Limited also operates in the contract research and manufacturing (CRAM) segment. Wikipedia

News for Pharmaceuticals and health care

India's Economic...
India's Economic Survey: Robust Growth, Inflation & FDI Concerns
India's economic survey shows strong growth but highlights concerns over inflation and FDI inflows, according to economists. Experts also discuss the impact of AI on employment and the need for...
Jul 22, 2024 22:36
Mahindra...
Mahindra Logistics Profit Drops 55% in Q1 FY25
Mahindra Logistics Ltd (MLL) reported a 55% decline in standalone profit to Rs 10.15 crore in the April-June quarter due to higher startup costs and expenses.
Jul 22, 2024 22:30
Mangaluru Airport...
Mangaluru Airport Passenger Traffic Rises 21% | Adani Airports
Mangaluru International Airport sees a 21% surge in passenger traffic in Q1 FY24-25, with Dubai leading international destinations and Bengaluru & Mumbai topping domestic travel. Air India Express...
Jul 22, 2024 22:17
CTTC to Set Up...
CTTC to Set Up Mini Tool Rooms in Odisha
Central Tool Room & Training Centre (CTTC) will set up mini tool rooms in Odisha to train youth in advanced manufacturing and precision engineering.
Jul 22, 2024 21:57
Suzlon Group Q1...
Suzlon Group Q1 Profit Soars 300%, Revenue Rises
Suzlon Group's Q1 PAT nearly tripled to Rs 302 crore on strong revenue growth. The company also boasts a record order book of 3.8 GW. Read more.
Jul 22, 2024 21:36

More News »

Top News

India's Economic...
India's Economic Survey: Robust Growth, Inflation & FDI Concerns
India's economic survey shows strong growth but highlights concerns over inflation and FDI inflows, according to economists. Experts also discuss the impact of AI on employment and the need for...
Jul 22, 2024 22:36
Mahindra...
Mahindra Logistics Profit Drops 55% in Q1 FY25
Mahindra Logistics Ltd (MLL) reported a 55% decline in standalone profit to Rs 10.15 crore in the April-June quarter due to higher startup costs and expenses.
Jul 22, 2024 22:30
India Rejects 'One-Size-Fits-All' Climate Approach: Chief Economic Advisor
India's Chief Economic Advisor criticizes the West's 'one-size-fits-all' approach to climate change, arguing developing nations need their own solutions. Read why.
Jul 22, 2024 22:28
Mangaluru Airport...
Mangaluru Airport Passenger Traffic Rises 21% | Adani Airports
Mangaluru International Airport sees a 21% surge in passenger traffic in Q1 FY24-25, with Dubai leading international destinations and Bengaluru & Mumbai topping domestic travel. Air India Express...
Jul 22, 2024 22:17
CTTC to Set Up...
CTTC to Set Up Mini Tool Rooms in Odisha
Central Tool Room & Training Centre (CTTC) will set up mini tool rooms in Odisha to train youth in advanced manufacturing and precision engineering.
Jul 22, 2024 21:57

More Top News »

Report Card

PE Ratios
27.97
EPS (Rs.)
17.99
Sales (Rs. Cr)
940.19
Face Value (Rs.)
1
Net Profit Margin (%)
12.68
Last Bonus
Last Dividend(%)
150
Return on Average Equity
18.56

Compare 'Granules India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Granules India Ltd. performance snapshot

If you had invested Rs.  in Granules India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Close
Add Granules India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Granules India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close